Results 131 to 140 of about 98,142 (313)

THE ROLE OF EXPECTATIONS AND HETEROGENEOUS PREFERENCES FOR CONGESTION IN THE VALUATION OF RECREATION BENEFITS [PDF]

open access: yes
Studies of recreation congestion generally utilize nonmarket valuation techniques to determine the use level and entrance price that maximize aggregate recreation benefits for a specific recreation area. This paper improves upon these previous studies by
Reiling, Stephen D., Michael, Jeffrey A.
core   +1 more source

Smart Window Adjustment for XCP’s Congestion Management [PDF]

open access: yes, 2012
[[abstract]]In the large bandwidth-delay product (BDP)networks, it has been demonstrated that the eXplicit Control Protocol, XCP, outperforms TCP and remains efficient, fair, and stable.
Yang, Yuan-Rung; Chan, Yi-Cheng; Chen, Yaw-Chung; Chan, Yi-Cheng
core  

Dynamic Boundary Dissemination to Virtual Power Plants for Congestion and Voltage Management in Power Distribution Networks

open access: yesEnergies
Virtual power plants (VPPs) are optimized to maximize profits by efficiently scheduling their resources. However, dynamic power trading over existing distribution networks can lead to voltage disturbances and branch congestion, posing risks to network ...
Khalil Gholami   +2 more
doaj   +1 more source

Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General‐Population Cohort Analysis With Extended Quantile g‐Computation

open access: yesArthritis &Rheumatology, EarlyView.
Objective The aim of this study was to investigate whether exposure to mixture of individual fine particulate matter (PM2.5) chemical constituents is associated with incident systemic lupus erythematosus (SLE) and if ozone modifies this association and/or is associated with SLE onset.
Naizhuo Zhao   +9 more
wiley   +1 more source

Does Expansion Cause Congestion? The Case of the Older British Universities, 1994 to 2004 [PDF]

open access: yes
This paper examines whether the rapid growth in the number of students in British universities in recent years has led to congestion, in the sense that certain universities’ output could have been higher if this expansion had been less rapid.
Tony Flegg, David O. Allen
core  

Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo‐Controlled Phase 3 Trials

open access: yesArthritis &Rheumatology, EarlyView.
Objective DISSOLVE I and II examined the efficacy and safety of nanoencapsulated sirolimus (NAS) plus pegadricase (NASP) in patients with uncontrolled gout (UG). Methods In these double‐blind, placebo‐controlled Phase 3 trials of NASP, patients were randomized 1:1:1 to infusions of high‐dose (HD) or low‐dose (LD) NAS plus pegadricase (HD NASP, LD NASP,
Herbert S. B. Baraf   +15 more
wiley   +1 more source

Congestion management for urban EV charging systems [PDF]

open access: yes
We consider the problem of managing Electric Vehicle (EV) charging at charging points in a city to ensure that the load on the charging points remains within the desired limits while minimizing the inconvenience to EV owners.
Rigas, Emmanouil   +3 more
core  

Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+‐year results from a multicenter, open‐label study

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients 2–17 years with active pcJIA and inadequate response ...
Hermine I Brunner   +28 more
wiley   +1 more source

Performance and Congestion Analysis of the Portuguese Hospital Services [PDF]

open access: yes
The health care services have been characterised by a growing demand by the citizens leading to the need of more and more resources. Population aging, new pathologies and drugs as well as new treatments are some of the major factors for this. However, in
Simões, Pedro, Cunha Marques, Rui
core   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy